SXRZ 📈 iShares VII - iShares - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00B52MJD48 • Japan Large-Cap Equity
SXRZ: Japanese, Stocks, Equities, Index, Funds, ETFs
The iShares VII PLC - iShares Nikkei 225 ETF JPY Acc, listed on XETRA as SXRZ, is a financial instrument designed to track the performance of the Japanese stock market, specifically the large-cap equity sector. It is issued by iShares, a subsidiary of BlackRock, one of the world's leading asset management companies, with its website available at http://www.blackrock.com. The fund is domiciled in Ireland, which provides a favorable regulatory environment for investment funds.
This ETF is categorized under Japan Large-Cap Equity, indicating its focus on the larger, more established companies in the Japanese market. The underlying index for this ETF is the Morningstar Japan TME NR JPY, which suggests a specific methodology for selecting and weighting the constituent stocks. The ISIN code for this ETF is IE00B52MJD48, a unique identifier used for trading and clearing purposes. As an exchange-traded fund (ETF), it offers investors the ability to buy and sell units on a stock exchange, providing flexibility and liquidity.
The choice of the Nikkei 225 as a reference index reflects the ETF's aim to replicate the performance of Japan's premier stock market index, which comprises the 225 most liquid stocks listed on the Tokyo Stock Exchange. By tracking this index, the iShares Nikkei 225 ETF JPY Acc provides investors with exposure to a broad range of Japanese industries and sectors, allowing for diversified investment in the Japanese economy. The fact that it is denominated in Japanese yen (JPY) and accrues income (indicated by 'JPY Acc') means that investors can benefit from the dividend payments made by the underlying stocks, potentially enhancing the overall return on investment.
Additional Sources for SXRZ ETF
SXRZ ETF Overview
Market Cap in USD | 61,061m |
Category | Japan Large-Cap Equity |
TER | 0.48% |
IPO / Inception | 2010-01-25 |
SXRZ ETF Ratings
Growth 5y | 38.1% |
Fundamental | - |
Dividend | - |
Rel. Strength Industry | -22.4 |
Analysts | - |
Fair Price Momentum | 227.39 EUR |
Fair Price DCF | - |
SXRZ Dividends
No Dividends PaidSXRZ Growth Ratios
Growth Correlation 3m | 32.2% |
Growth Correlation 12m | 42.9% |
Growth Correlation 5y | 60.5% |
CAGR 5y | 5.21% |
CAGR/Mean DD 5y | 0.57 |
Sharpe Ratio 12m | 0.51 |
Alpha | -3.85 |
Beta | 0.57 |
Volatility | 14.62% |
Current Volume | 0.8k |
Average Volume 20d | 1.3k |
As of December 22, 2024, the stock is trading at EUR 240.55 with a total of 829 shares traded.
Over the past week, the price has changed by -3.69%, over one month by +2.26%, over three months by +1.46% and over the past year by +14.48%.
Partly, yes. Based on ValueRay Analyses, iShares VII - iShares (XETRA:SXRZ) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 38.11 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SXRZ as of December 2024 is 227.39. This means that SXRZ is currently overvalued and has a potential downside of -5.47%.
iShares VII - iShares has no consensus analysts rating.
According to ValueRays Forecast Model, SXRZ iShares VII - iShares will be worth about 249.4 in December 2025. The stock is currently trading at 240.55. This means that the stock has a potential upside of +3.68%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 249.4 | 3.7% |